Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet regimen for controlling HIV infection. This drug integrates three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the virus's ability to copy within the body, significantly lowering the viral load. F